Union européenne - français - EMA (European Medicines Agency)

sanofi b.v. - thyrotropine alfa - néoplasmes thyroïdiens - lobe antérieur de l'hypophyse hormones et analogues, l'hypophyse et les hormones hypothalamiques et analogues - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - thyrotropinum alfa - poudre versez solution injectable - praeparatio cryodesiccata: thyrotropinum alfa 0.9 mg, mannitolum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, pro vitro corresp. natrium 1.19 mg. - cancer de la thyroïde - biotechnologika

Canada - français - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - thyrotropine alfa - poudre pour solution - 0.9mg - thyrotropine alfa 0.9mg - thyroid function

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

alfasigma schweiz ag - levothyroxinum natricum anhydricum - 0.05 mg, comprimés - levothyroxinum natricum anhydricum 50 µg ut levothyroxinum natricum, cellulosum microcristallinum, amylum pregelificatum, talcum, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 1.4 µg. - hypothyreose - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

alfasigma schweiz ag - levothyroxinum natricum anhydricum - 0.1 mg, comprimés - levothyroxinum natricum anhydricum 100 µg ut levothyroxinum natricum, cellulosum microcristallinum, amylum pregelificatum, talcum, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 2.8 µg. - hypothyreose - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

alfasigma schweiz ag - betamethasonum - comprimés - betamethasonum 0.5 mg ut betamethasoni natrii phosphas, natrii hydrogenocarbonas, dinatrii citras sesquihydricus, povidonum, saccharinum natricum, e 211 6 mg, e 127, pro compresso corresp. natrium 22.23 mg. - glukokortikosteroid-therapie - synthetika

France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

ferring sas - protiréline anhydre - solution - 0,125 mg - composition pour 1 ml de solution injectable > protiréline anhydre : 0,125 mg . sous forme de : protiréline - tests pour la fonction thyroidienne

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - levothyroxinum natricum - soft capsule - levothyroxinum natricum 25 µg, gelatina hydrolysata, gelatina, glycerolum, aqua purificata, pro capsula corresp. natrium max. 0.005 mg. - ipotiroidismo - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - levothyroxinum natricum - soft capsule - levothyroxinum natricum 50 µg, gelatina hydrolysata, gelatina, glycerolum, aqua purificata, pro capsula corresp. natrium max. 0.005 mg. - ipotiroidismo - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - levothyroxinum natricum - soft capsule - levothyroxinum natricum 75 µg, gelatina hydrolysata, gelatina, glycerolum, aqua purificata, pro capsula corresp. natrium max. 0.005 mg. - ipotiroidismo - synthetika